Heading into 2024, companies face elevated interest rates, weak liquidity and no appetite from lenders for highly-leveraged capital structures. Global By Susan Morse , Associate Editor, Healthcare Finance News | December 6, 2023 | 4:45 PM Photo: Kittiphan Teerawattanakul/Eye Em/Getty Images